The ALS Association is hosting ALS Community Workshop: Developing Drugs for Treatment, Guidance for Industry on July 12 in Washington, D.C., and the entire ALS community is invited.
The goal of the workshop will be to provide targeted feedback and information to the Food and Drug Administration (FDA) from people with ALS, caregivers, and stakeholders to inform revisions of the FDA’s Draft Guidance on ALS Drug Development.
While technical information will be included, the workshop is a unique opportunity to share the ALS patient voice with the FDA and the pharmaceutical industry.
For those unable to attend in person, the event will be live streamed and recorded, and online attendees will have the opportunity to make comments during the live workshop. We will share more information on the live stream closer to the date of the workshop.
For more detailed information, travel details, a workshop overview, and more, click here. Information will updated periodically, so please check the website frequently.